A small-molecule-controlled system for efficient pseudotyping of prototype foamy virus vectors

Molecular Therapy

Volumn 20, Issue 6, 2012, Pages 1167-1176

  Ho, Yu Ping ^a,b   Schnabel, Viktor ^a,b   Swiersy, Anka ^a,b   Stirnnagel, Kristin ^a,b   Lindemann, Dirk ^a,b  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b CENTER FOR REGENERATIVE THERAPIES DRESDEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; ENHANCED GREEN FLUORESCENT PROTEIN; GAG PROTEIN; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN; VIRUS VECTOR;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; FLOW CYTOMETRY; GENE TRANSFER; NONHUMAN; PROTEIN EXPRESSION; PSEUDOTYPING; SPUMA VIRUS; VIRAL TROPISM; VIRUS CAPSID; VIRUS PARTICLE; WESTERN BLOTTING;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN SPUMARETROVIRUS; MIRIDAE; VESICULAR STOMATITIS VIRUS;

EID: 84861848109     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2012.61     Document Type: Article

References (30)

1. Cronin, J, Zhang, XY and Reiser, J (2005). Altering the tropism of lentiviral vectors through pseudotyping. Curr Gene Ther 5: 387-398. (Pubitemid 41052430)
2. Colin, A, Faideau, M, Dufour, N, Auregan, G, Hassig, R, Andrieu, T et al. (2009). Engineered lentiviral vector targeting astrocytes in vivo. Glia 57: 667-679.
3. Miletic, H, Fischer, YH, Neumann, H, Hans, V, Stenzel, W, Giroglou, T et al. (2004). Selective transduction of malignant glioma by lentiviral vectors pseudotyped with lymphocytic choriomeningitis virus glycoproteins. Hum Gene Ther 15: 1091-1100. (Pubitemid 39552290)
4. Kato, S, Inoue, K, Kobayashi, K, Yasoshima, Y, Miyachi, S, Inoue, S et al. (2007). Efficient gene transfer via retrograde transport in rodent and primate brains using a human immunodeficiency virus type 1-based vector pseudotyped with rabies virus glycoprotein. Hum Gene Ther 18: 1141-1151. (Pubitemid 350114690)
5. Buchholz, CJ, Mühlebach, MD and Cichutek, K (2009). Lentiviral vectors with measles virus glycoproteins - dream team for gene transfer? Trends Biotechnol 27: 259-265.
6. Rethwilm, A (2010). Molecular biology of foamy viruses. Med Microbiol Immunol 199: 197-207.
7. Lindemann, D and Rethwilm, A (2011). Foamy virus biology and its application for vector development. Viruses 3: 561-585.
8. Fischer, N, Heinkelein, M, Lindemann, D, Enssle, J, Baum, C, Werder, E et al. (1998). Foamy virus particle formation. J Virol 72: 1610-1615. (Pubitemid 28116950)
9. Lindemann, D, Pietschmann, T, Picard-Maureau, M, Berg, A, Heinkelein, M, Thurow, J et al. (2001). A particle-associated glycoprotein signal peptide essential for virus maturation and infectivity. J Virol 75: 5762-5771. (Pubitemid 32553108)
10. Wilk, T, Geiselhart, V, Frech, M, Fuller, SD, Flügel, RM and Löchelt, M (2001). Specific interaction of a novel foamy virus Env leader protein with the N-terminal Gag domain. J Virol 75: 7995-8007. (Pubitemid 32743671)
11. Pietschmann, T, Heinkelein, M, Heldmann, M, Zentgraf, H, Rethwilm, A and Lindemann, D (1999). Foamy virus capsids require the cognate envelope protein for particle export. J Virol 73: 2613-2621. (Pubitemid 29135645)
12. Abe, A, Chen, ST, Miyanohara, A and Friedmann, T (1998). In vitro cell-free conversion of noninfectious Moloney retrovirus particles to an infectious form by the addition of the vesicular stomatitis virus surrogate envelope G protein. J Virol 72: 6356-6361. (Pubitemid 28323946)
13. Strang, BL, Ikeda, Y, Cosset, FL, Collins, MK and Takeuchi, Y (2004). Characterization of HIV-1 vectors with gammaretrovirus envelope glycoproteins produced from stable packaging cells. Gene Ther 11: 591-598. (Pubitemid 38455977)
14. Hill, CL, Bieniasz, PD and McClure, MO (1999). Properties of human foamy virus relevant to its development as a vector for gene therapy. J Gen Virol 80 (Pt 8): 2003-2009. (Pubitemid 29389136)
15. Stirnnagel, K, Lüftenegger, D, Stange, A, Swiersy, A, Müllers, E, Reh, J et al. (2010). Analysis of prototype foamy virus particle-host cell interaction with autofluorescent retroviral particles. Retrovirology 7: 45.
16. Eastman, SW and Linial, ML (2001). Identification of a conserved residue of foamy virus Gag required for intracellular capsid assembly. J Virol 75: 6857-6864. (Pubitemid 32641572)
17. Life, RB, Lee, EG, Eastman, SW and Linial, ML (2008). Mutations in the amino terminus of foamy virus Gag disrupt morphology and infectivity but do not target assembly. J Virol 82: 6109-6119. (Pubitemid 351875093)
18. Zhadina, M, McClure, MO, Johnson, MC and Bieniasz, PD (2007). Ubiquitindependent virus particle budding without viral protein ubiquitination. Proc Natl Acad Sci USA 104: 20031-20036.
19. DuBridge, RB, Tang, P, Hsia, HC, Leong, PM, Miller, JH and Calos, MP (1987). Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol Cell Biol 7: 379-387. (Pubitemid 17230421)
20. Rasheed, S, Nelson-Rees, WA, Toth, EM, Arnstein, P and Gardner, MB (1974). Characterization of a newly derived human sarcoma cell line (HT-1080). Cancer 33: 1027-1033.
21. Whitmore, D, Foulkes, NS and Sassone-Corsi, P (2000). Light acts directly on organs and cells in culture to set the vertebrate circadian clock. Nature 404: 87-91. (Pubitemid 30143138)
22. Müllers, E, Uhlig, T, Stirnnagel, K, Fiebig, U, Zentgraf, H and Lindemann, D (2011). Novel functions of prototype foamy virus Gag glycine- arginine-rich boxes in reverse transcription and particle morphogenesis. J Virol 85: 1452-1463.
23. Sena-Esteves, M, Tebbets, JC, Steffens, S, Crombleholme, T and Flake, AW (2004). Optimized large-scale production of high titer lentivirus vector pseudotypes. J Virol Methods 122: 131-139. (Pubitemid 39470183)
24. Mochizuki, H, Schwartz, JP, Tanaka, K, Brady, RO and Reiser, J (1998). High-titer human immunodeficiency virus type 1-based vector systems for gene delivery into nondividing cells. J Virol 72: 8873-8883. (Pubitemid 28471831)
25. Amer, DA, Kretzschmar, G, Müller, N, Stanke, N, Lindemann, D and Vollmer, G (2010). Activation of transgenic estrogen receptor-beta by selected phytoestrogens in a stably transduced rat serotonergic cell line. J Steroid Biochem Mol Biol 120: 208-217.
26. Belshaw, PJ, Ho, SN, Crabtree, GR and Schreiber, SL (1996). Controlling protein association and subcellular localization with a synthetic ligand that induces heterodimerization of proteins. Proc Natl Acad Sci USA 93: 4604-4607. (Pubitemid 26162809)
27. Lindemann, D, Bock, M, Schweizer, M and Rethwilm, A (1997). Efficient pseudotyping of murine leukemia virus particles with chimeric human foamy virus envelope proteins. J Virol 71: 4815-4820. (Pubitemid 27204176)
28. Mannigel, I, Stange, A, Zentgraf, H and Lindemann, D (2007). Correct capsid assembly mediated by a conserved YXXLGL motif in prototype foamy virus Gag is essential for infectivity and reverse transcription of the viral genome. J Virol 81: 3317-3326. (Pubitemid 46456640)
29. Duda, A, Stange, A, Lüftenegger, D, Stanke, N, Westphal, D, Pietschmann, T et al. (2004). Prototype foamy virus envelope glycoprotein leader peptide processing is mediated by a furin-like cellular protease, but cleavage is not essential for viral infectivity. J Virol 78: 13865-13870. (Pubitemid 39612783)
30. Yu, SF, Eastman, SW and Linial, ML (2006). Foamy virus capsid assembly occurs at a pericentriolar region through a cytoplasmic targeting/retention signal in Gag. Traffic 7: 966-977.